Safety/Quality

Latest Issue of OR Manager
April 2019
Home Safety/Quality

IV and oral acetaminophen work equally well after THA

Editor's Note Intravenous (IV) acetaminophen did not result in a significant difference in pain scores, opioid consumption, or opioid-related adverse events compared with oral acetaminophen, finds this study presented March 12 at the American Academy of Orthopaedic Surgeons Annual Meeting in Las Vegas. A total of 154 patients having total…

Read More

By: Judy Mathias
March 13, 2019
Share

Discharging surgical patients earlier in the day linked to LOS, hospital throughput

Editor's Note A 12-month targeted initiative to discharge surgical patients earlier was associated with a 50% increase in patients being discharged by noon in this study. The initiative, which included preoperative and inpatient components: increased discharge by noon rates from 14.3% to 21.5% decreased length of stay (LOS) from 2.17…

Read More

By: Judy Mathias
March 11, 2019
Share

FDA issues letter on risks linked with staplers, implantable staples

Editor's Note The Food and Drug Administration (FDA) on March 8 issued a letter to alert healthcare providers about an increasing number of medical device reports on surgical staplers for internal use and implantable surgical staples. The most common reported problems include opening of the staple line, malformation of staples,…

Read More

By: Judy Mathias
March 11, 2019
Share

Bacterial contamination of white coats, surgical scrubs

Editor's Note Provider attire is a potential source of pathogenic bacterial transmission in healthcare settings, this review study finds. A total of 22 articles were included in this analysis, which found that provider attire was commonly colonized by multidrug-resistant organisms (MDROs), with white coats laundered less frequently than scrubs. The…

Read More

By: Judy Mathias
March 11, 2019
Share

Joint Commission moves THKR performance measures

Editor's Note The Joint Commission on March 6 announced that it is moving the inpatient and outpatient Total Hip and Total Knee Replacement (THKR) implementation guides from the performance measure webpage to the 2019 Specifications Manual for Joint Commission National Quality Measures. The Manual was published in February. The move will…

Read More

By: Judy Mathias
March 11, 2019
Share

Haven is new name for Amazon-backed healthcare venture

Editor's Note The healthcare organization founded by Amazon, Berkshire Hathaway, and JP Morgan Chase announced on March 6 its new name−Haven−along with the launching of its new website www.havenhealthcare.com. The website outlines some of the areas where Haven intends to make improvements on the current healthcare system, including access of…

Read More

By: Judy Mathias
March 7, 2019
Share

Failure to debrief after anesthesia critical events tied to communication breakdowns

Editor's Note Failure to debrief after critical events is common in anesthesia trainees and teams, and communication breakdowns are associated with the failure to debrief, this study finds. Over a 1-year period at a large academic medical center, anesthesiology residents and some attending anesthesiologists were audited and/or interviewed about the…

Read More

By: Judy Mathias
March 7, 2019
Share

Joint Commission: March 15 is deadline for CY 2018 eCQM data submission

Editor's Note The Joint Commission on March 6 reminded organizations submitting CY 2018 electronic clinical quality measure (eCQM) data that the deadline is 8 pm CT on March 15. Two submission methods are available: Listed ORYX eCQM Vendor. Direct Data Submission Platform. There will be no extensions, and data cannot…

Read More

By: Judy Mathias
March 7, 2019
Share

Preop frailty linked to surgical outcomes

Editor's Note In this study of adult surgical patients across all ages, frailty was associated with higher postoperative rates of major illness and readmissions as well as increased costs. Of 14,530 patients (31.9% inpatient, 68.1% outpatient) analyzed, 3.4% had high frailty (5.3% of inpatients and 2.5% of outpatients). Compared with…

Read More

By: Judy Mathias
March 6, 2019
Share

FDA: Class I recall of RVO 2.0 Raindrop near vision inlay

Editor's Note The Food & Drug Administration (FDA) on March 5 identified the recall by RVO 2.0, Inc (Aliso Viejo, California) of its Raindrop near vision inlay as Class I, the most serious. All lots of the inlay are being recalled because data from the post-approval study showed an increased…

Read More

By: Judy Mathias
March 6, 2019
Share
Upcoming Webinars
Live chat by BoldChat